Buprenorphine for Chronic Pain : A Safer Alternative to Traditional Opioids

With the ongoing public health crisis with prescription opioids, there is a need for safer alternatives for medication management in chronic pain patients. Buprenorphine is a partial mu-opioid agonist which is commonly utilized to treat patients with opioid-use disorders. The purpose of this review is to discuss the potential use of this medication for the treatment of chronic pain instead of resorting to more traditional Schedule II opioids. Buprenorphine offers a safer alternative for patients who require opioids to manage chronic pain, given the unique pharmacological properties that allow it to provide adequate analgesia with less abuse potential.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:9

Enthalten in:

Health psychology research - 9(2021), 1 vom: 26., Seite 27241

Sprache:

Englisch

Beteiligte Personen:

Dalal, Suhani [VerfasserIn]
Chitneni, Ahish [VerfasserIn]
Berger, Amnon A [VerfasserIn]
Orhurhu, Vwaire [VerfasserIn]
Dar, Bilal [VerfasserIn]
Kramer, Bennett [VerfasserIn]
Nguyen, Anvinh [VerfasserIn]
Pruit, John [VerfasserIn]
Halsted, Charles [VerfasserIn]
Kaye, Alan D [VerfasserIn]
Hasoon, Jamal [VerfasserIn]

Links:

Volltext

Themen:

Analgesics
Buprenorphine
Chronic pain
Journal Article
Opioids
Review

Anmerkungen:

Date Revised 01.02.2022

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.52965/001c.27241

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM332845419